WarfarinEmbryopathy following in-utero exposure: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1725卷 / 1期

关键词：

D O I：

10.1007/s40278-018-53634-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：293 / 293

相关论文

共 50 条

[41] TerbutalineFetal tachyarrhythmia following in-utero exposure: case report
Reactions Weekly, 2022, 1893 (1) : 307 - 307
[42] ValaciclovirLack of efficacy following in-utero exposure: case report
Reactions Weekly, 2024, 2027 (1) : 482 - 482
[43] MethotrexateFallot tetralogy following in-utero exposure: case report
Reactions Weekly, 2016, 1629 (1) : 159 - 159
[44] DigoxinLack of efficacy following in-utero exposure: case report
Reactions Weekly, 2022, 1919 (1) : 233 - 233
[45] IsotretinoinVarious toxicities following in-utero exposure : case report
Reactions Weekly, 2023, 1984 (1) : 294 - 294
[46] DexamethasoneLack of efficacy following in-utero exposure: case report
Reactions Weekly, 2023, 1974 (1) : 130 - 130
[47] Carboplatin/paclitaxelDeafness following an in-utero exposure: case report
Reactions Weekly, 2018, 1728 (1) : 88 - 88
[48] WarfarinEmbryopathy in fetuses following in utero exposure: 3 case reports
Reactions Weekly, 2010, 1307 (1) : 45 - 45
[49] MisoprostolFoetal bradycardia following in-utero drug exposure: case report
Reactions Weekly, 2025, 2049 (1) : 223 - 223
[50] Prednisone acetateCleft lip following in-utero exposure: case report
Reactions Weekly, 2022, 1890 (1) : 219 - 219

← 1 2 3 4 5 →